Cargando…
The Clinicopathological and Prognostic Value of PD-L1 Expression in Cholangiocarcinoma: A Meta-Analysis
Background: Recently, blockade of immune checkpoint has emerged as one of the most potential treatments for solid tumors. Programmed cell death ligand 1(PD-L1), a member of the B7 family of molecules, plays a crucial role in tumor immunobiology. However, the prognostic significance of PD-L1 in chola...
Autores principales: | Xu, Gang, Sun, Lejia, Li, Yunzhu, Xie, Feihu, Zhou, Xiaoxiang, Yang, Huayu, Du, Shunda, Xu, Haifeng, Mao, Yilei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6759577/ https://www.ncbi.nlm.nih.gov/pubmed/31620360 http://dx.doi.org/10.3389/fonc.2019.00897 |
Ejemplares similares
-
Correlation Between PD-L2 Expression and Clinical Outcome in Solid Cancer Patients: A Meta-Analysis
por: Yang, Huayu, et al.
Publicado: (2019) -
Clinicopathologic and prognostic significance of regulatory T cells in patients with hepatocellular carcinoma: a meta-analysis
por: Sun, Lejia, et al.
Publicado: (2017) -
The Prognostic Value of Systemic Inflammation Response Index in Cholangiocarcinoma Patients
por: Jin, Bao, et al.
Publicado: (2021) -
Identification of RASSF1A promoter hypermethylation as a biomarker for hepatocellular carcinoma
por: Xu, Gang, et al.
Publicado: (2020) -
The Impacts of Systemic Immune-Inflammation Index on Clinical Outcomes in Gallbladder Carcinoma
por: Sun, Lejia, et al.
Publicado: (2020)